[Analysis of genetic polymorphisms and drug resistance mutations in the NS5 region of HCV genome (Flasuviricetes: Amarillovirales: Flaviviridae: Hepacivirus C) in samples obtained in 2022-2023 from HIV-infected treatment-naive residents of Altai Krai].

I A Lapovok, A V Syrkina, A A Kirichenko, A V Shlykova, N V Lukyanenko, T V Safyanova, A E Safronova, V V Shevchenko, D E Kireev